Osteotropic Cancers: From Primary Tumor to Bone (Q58327148)

Maria Felicia Faienza

3

0 references

Giacomina Brunetti

Giacomina Brunetti

1

0 references

Silvia Colucci

Silvia Colucci

4

0 references

Maria Grano

Maria Grano

Clinical reviews in bone and mineral metabolism

5

0 references

publication date

17 October 2013

0 references

published in

0 references

volume

11

0 references

page(s)

94-102

0 references

issue

3-4

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12018-013-9147-0

0 references

cites work

Management of bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Genetic determinants of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Epigenetic contributions to cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

EMT, the cytoskeleton, and cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Integrins in bone metastasis formation and potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Role of the metastasis-promoting protein osteopontin in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

COX-2 involvement in breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

COX-2 induces IL-11 production in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The IGF‐1 receptor in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Hypoxic gene expression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Regulation of bone cell function by acid–base balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Microenvironmental and cellular consequences of altered blood flow in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Acid-mediated tumor invasion: a multidisciplinary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Regulation of cancer metastasis by stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Bone metastasis: Osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Stromal-epithelial interaction in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Roles of osteonectin in the migration of breast cancer cells into bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Bone metastasis: pathogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Osteoprotegrin and the bone homing and colonization potential of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Genetic regulation of osteoclast development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Sclerostin is overexpressed by plasma cells from multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Myeloma cells suppress osteoblasts through sclerostin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Mechanisms of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The Interplay between the bone and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Interaction among cells of bone, immune system, and solid tumors leads to bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

CD8+ T cells regulate bone tumor burden independent of osteoclast resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0

Denosumab for the treatment of bone metastases in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12018-013-9147-0